Glucantime Susceptibility of Leishmania Promastigotes Under Variable Growth Conditions

Overview

Journal Parasitol Res

Specialty Parasitology

Date 1995 Jan 1

PMID 7624285

Citations 5

Authors

E S Moreira

R M Soares

Affiliations

Soon will be listed here.

Abstract

Growth inhibition of Leishmania promastigotes by glucantime was compared in three different media. Glucantime inhibited the growth of Leishmania cultured in complex medium but did not affect parasite growth when added to cells cultured in defined or semi-defined media. Supplementation of the complex medium with biopterin partially reversed the glucantime effect in sensitive strains, although the addition of folic acid or oleic acid did not alter the activity of glucantime. Differences in fatty acid composition were observed between strains showing different degrees of glucantime susceptibility.

Citing Articles

Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery.

Bhattacharya A, Corbeil A, do Monte-Neto R, Fernandez-Prada C Genes (Basel). 2020; 11(7).

PMID: 32610603 PMC: 7397081. DOI: 10.3390/genes11070722.

Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia.

Franco-Munoz C, Manjarres-Estremor M, Ovalle-Bracho C PLoS One. 2018; 13(4):e0196247.

PMID: 29698432 PMC: 5919572. DOI: 10.1371/journal.pone.0196247.

In Vitro Sensitivity of Cutaneous Promastigote Isolates Circulating in French Guiana to a Set of Drugs.

Ginouves M, Simon S, Nacher M, Demar M, Carme B, Couppie P Am J Trop Med Hyg. 2017; 96(5):1143-1150.

PMID: 28167598 PMC: 5417208. DOI: 10.4269/ajtmh.16-0373.

Simple colorimetric trypanothione reductase-based assay for high-throughput screening of drugs against Leishmania intracellular amastigotes.

Bogaart E, Schoone G, England P, Faber D, Orrling K, Dujardin J Antimicrob Agents Chemother. 2013; 58(1):527-35.

PMID: 24189262 PMC: 3910791. DOI: 10.1128/AAC.00751-13.

Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents.

Sereno D, Lemesre J Antimicrob Agents Chemother. 1997; 41(5):972-6.

PMID: 9145854 PMC: 163835. DOI: 10.1128/AAC.41.5.972.

References

Croft S . In vitro screens in the experimental chemotherapy of leishmaniasis and trypanosomiasis. Parasitol Today. 1986; 2(3):64-9. DOI: 10.1016/0169-4758(86)90157-2. View

Kaur K, Emmett K, McCann P, SJOERDSMA A, Ullman B . Effects of DL-alpha-difluoromethylornithine on Leishmania donovani promastigotes. J Protozool. 1986; 33(4):518-21. DOI: 10.1111/j.1550-7408.1986.tb05654.x. View

Sadigursky M, Brodskyn C . A new liquid medium without blood and serum for culture of hemoflagellates. Am J Trop Med Hyg. 1986; 35(5):942-4. DOI: 10.4269/ajtmh.1986.35.942. View

Nilsson O, Svennerholm L . Characterization and quantitative determination of gangliosides and neutral glycosphingolipids in human liver. J Lipid Res. 1982; 23(2):327-34. View

Berman J, Waddell D, Hanson B . Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate. Antimicrob Agents Chemother. 1985; 27(6):916-20. PMC: 180186. DOI: 10.1128/AAC.27.6.916. View

Singer S . The molecular organization of membranes. Annu Rev Biochem. 1974; 43(0):805-33. DOI: 10.1146/annurev.bi.43.070174.004105. View

Grimaldi Jr G . Leishmaniasis and its etiologic agents in the New World: an overview. Prog Clin Parasitol. 1991; 2:73-118. View

Figueiredo Y, Da Costa C, Mayrink W, Araujo F, Dias M, Melo M . [Nutrition and metabolism of Leishmania culture forms]. Rev Inst Med Trop Sao Paulo. 1976; 18(5):306-14. View

Peixoto M, Beverley S . In vitro activity of sulfonamides and sulfones against Leishmania major promastigotes. Antimicrob Agents Chemother. 1987; 31(10):1575-8. PMC: 174993. DOI: 10.1128/AAC.31.10.1575. View

10.

DEWEY V, KIDDER G . Effects of long-chain mono- and dicarboxylic acids on the pteridine requirement of Crithidia. Arch Biochem Biophys. 1966; 115(2):401-6. DOI: 10.1016/0003-9861(66)90289-x. View

11.

Nolan T, Herman R . Effects of long-term in vitro cultivation on Leishmania donovani promastigotes. J Protozool. 1985; 32(1):70-5. DOI: 10.1111/j.1550-7408.1985.tb03015.x. View

12.

Mottram J, Coombs G . Leishmania mexicana: enzyme activities of amastigotes and promastigotes and their inhibition by antimonials and arsenicals. Exp Parasitol. 1985; 59(2):151-60. DOI: 10.1016/0014-4894(85)90067-0. View

13.

Melo N, de Azevedo H, Roitman I, Mayrink W . A new defined medium for cultivating Leishmania promastigotes. Acta Trop. 1985; 42(2):137-41. View

14.

HAKOMORI S, Murakami W . Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines. Proc Natl Acad Sci U S A. 1968; 59(1):254-61. PMC: 286029. DOI: 10.1073/pnas.59.1.254. View

15.

Fish W, HOLZ Jr G, Beach D, Owen E, Anekwe G . The cyclopropane fatty acid of trypanosomatids. Mol Biochem Parasitol. 1981; 3(2):103-15. DOI: 10.1016/0166-6851(81)90010-4. View

16.

Hunter K, Strobos C, Fairlamb A . Inhibition of polyamine biosynthesis in Crithidia fasciculata by D,L-alpha-difluoromethylornithine and D,L-alpha-difluoromethylarginine. Mol Biochem Parasitol. 1991; 46(1):35-43. DOI: 10.1016/0166-6851(91)90196-d. View

17.

Scott D, Coombs G, Sanderson B . Folate utilisation by Leishmania species and the identification of intracellular derivatives and folate-metabolising enzymes. Mol Biochem Parasitol. 1987; 23(2):139-49. DOI: 10.1016/0166-6851(87)90149-6. View

18.

Pacheco R, Grimaldi Jr G, Momen H, Morel C . Population heterogeneity among clones of New World Leishmania species. Parasitology. 1990; 100 Pt 3:393-8. DOI: 10.1017/s0031182000078677. View

19.

Moreira E . In vitro activity of meglumine antimoniate, a pentavalent antimonial drug, on Leishmania promastigotes. Braz J Med Biol Res. 1991; 24(5):459-69. View

20.

FORREST H, Van Baalen C . Microbiology of unconjugated pteridines. Annu Rev Microbiol. 1970; 24:91-108. DOI: 10.1146/annurev.mi.24.100170.000515. View